228 related articles for article (PubMed ID: 22564714)
1. Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies.
Trudel D; Labbé DP; Bairati I; Fradet V; Bazinet L; Têtu B
Gynecol Oncol; 2012 Sep; 126(3):491-8. PubMed ID: 22564714
[TBL] [Abstract][Full Text] [Related]
2. Tea consumption and epithelial ovarian cancer risk: a systematic review of observational studies.
Oppeneer SJ; Robien K
Nutr Cancer; 2011; 63(6):817-26. PubMed ID: 21800977
[TBL] [Abstract][Full Text] [Related]
3. Possible role for green tea in ovarian cancer prevention.
Lee AH; Fraser ML; Binns CW
Future Oncol; 2005 Dec; 1(6):771-7. PubMed ID: 16556056
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.
Bae KH; Tan S; Yamashita A; Ang WX; Gao SJ; Wang S; Chung JE; Kurisawa M
Biomaterials; 2017 Dec; 148():41-53. PubMed ID: 28961534
[TBL] [Abstract][Full Text] [Related]
5. Procyanidin-rich extract of natural cocoa powder causes ROS-mediated caspase-3 dependent apoptosis and reduction of pro-MMP-2 in epithelial ovarian carcinoma cell lines.
Taparia SS; Khanna A
Biomed Pharmacother; 2016 Oct; 83():130-140. PubMed ID: 27470560
[TBL] [Abstract][Full Text] [Related]
6. Green tea consumption enhances survival of epithelial ovarian cancer.
Zhang M; Lee AH; Binns CW; Xie X
Int J Cancer; 2004 Nov; 112(3):465-9. PubMed ID: 15382073
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
8. Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target.
Saed GM; Fletcher NM; Diamond MP; Morris RT; Gomez-Lopez N; Memaj I
Gynecol Oncol; 2018 Mar; 148(3):567-575. PubMed ID: 29329880
[TBL] [Abstract][Full Text] [Related]
9. Breastfeeding and ovarian cancer risk: a systematic review and meta-analysis of 40 epidemiological studies.
Li DP; Du C; Zhang ZM; Li GX; Yu ZF; Wang X; Li PF; Cheng C; Liu YP; Zhao YS
Asian Pac J Cancer Prev; 2014; 15(12):4829-37. PubMed ID: 24998548
[TBL] [Abstract][Full Text] [Related]
10. Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer.
Wang Y; Mao H; Hao Q; Wang Y; Yang Y; Shen L; Huang S; Liu P
Regul Pept; 2012 Oct; 178(1-3):36-42. PubMed ID: 22759793
[TBL] [Abstract][Full Text] [Related]
11. Tea, coffee, and caffeinated beverage consumption and risk of epithelial ovarian cancers.
Leung AC; Cook LS; Swenerton K; Gilks B; Gallagher RP; Magliocco A; Steed H; Köbel M; Nation J; Brooks-Wilson A; Le ND
Cancer Epidemiol; 2016 Dec; 45():119-125. PubMed ID: 27810483
[TBL] [Abstract][Full Text] [Related]
12. Coffee, tea, and caffeine consumption and risk of epithelial ovarian cancer and borderline ovarian tumors: Results from a Danish case-control study.
Gosvig CF; Kjaer SK; Blaakær J; Høgdall E; Høgdall C; Jensen A
Acta Oncol; 2015; 54(8):1144-51. PubMed ID: 25629440
[TBL] [Abstract][Full Text] [Related]
13. Survivin status affects prognosis and chemosensitivity in epithelial ovarian cancer.
Chen L; Liang L; Yan X; Liu N; Gong L; Pan S; Lin F; Zhang Q; Zhao H; Zheng F
Int J Gynecol Cancer; 2013 Feb; 23(2):256-63. PubMed ID: 23358177
[TBL] [Abstract][Full Text] [Related]
14. Hormone response in ovarian cancer: time to reconsider as a clinical target?
Modugno F; Laskey R; Smith AL; Andersen CL; Haluska P; Oesterreich S
Endocr Relat Cancer; 2012 Dec; 19(6):R255-79. PubMed ID: 23045324
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
Spinella F; Rosanò L; Decandia S; Di Castro V; Albini A; Elia G; Natali PG; Bagnato A
Exp Biol Med (Maywood); 2006 Jun; 231(6):1123-7. PubMed ID: 16741061
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of oral cancer by green tea.
Hsu SD; Singh BB; Lewis JB; Borke JL; Dickinson DP; Drake L; Caughman GB; Schuster GS
Gen Dent; 2002; 50(2):140-6. PubMed ID: 12004708
[TBL] [Abstract][Full Text] [Related]
17. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
18. Green and black tea in relation to gynecologic cancers.
Butler LM; Wu AH
Mol Nutr Food Res; 2011 Jun; 55(6):931-40. PubMed ID: 21595018
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets for green tea in prostate cancer prevention.
Adhami VM; Ahmad N; Mukhtar H
J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis on Molecular Mechanism of Green Tea Compound Epigallocatechin-3-Gallate Against Ovarian Cancer.
Xinqiang S; Mu Z; Lei C; Mun LY
Clin Transl Sci; 2017 Jul; 10(4):302-307. PubMed ID: 28504421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
